344 related articles for article (PubMed ID: 32645077)
1. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
2. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
[TBL] [Abstract][Full Text] [Related]
3. Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients.
Ruscitti P; Berardicurti O; Iacono D; Pantano I; Liakouli V; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Barile A; Cipriani P; Giacomelli R
Arthritis Res Ther; 2020 Jun; 22(1):151. PubMed ID: 32571407
[TBL] [Abstract][Full Text] [Related]
4. Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.
Ruscitti P; Di Cola I; Berardicurti O; Conforti A; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Giacomelli R; Cipriani P
Clin Rheumatol; 2022 Mar; 41(3):641-647. PubMed ID: 34636022
[TBL] [Abstract][Full Text] [Related]
5. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort.
Di Cola I; Iacono D; Pantano I; Mauro D; Vitale A; Caso F; De Stefano L; Prete M; Navarini L; Ciaffi J; Ursini F; Costa L; Perosa F; Montecucco C; Cantarini L; Frediani B; Ciccia F; Giacomelli R; Cipriani P; Ruscitti P
Joint Bone Spine; 2023 Sep; 90(5):105576. PubMed ID: 37080283
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
9. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
[TBL] [Abstract][Full Text] [Related]
10. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.
Seo JY; Suh CH; Jung JY; Kim AR; Yang JW; Kim HA
Medicine (Baltimore); 2017 Jul; 96(29):e7546. PubMed ID: 28723775
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
13. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset Still's disease with elderly onset: results from a multicentre study.
Di Cola I; Di Muzio C; Conforti A; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Bugatti S; Montecucco C; Ciccia F; Giacomelli R; Cipriani P; Ruscitti P
Clin Exp Rheumatol; 2022 Sep; 40(8):1517-1525. PubMed ID: 35579097
[TBL] [Abstract][Full Text] [Related]
15. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
18. Measurement of glycosylated ferritin with Concanavalin A: Assay design, optimization and validation.
Raynor A; Peoc'h K; Boutten A
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123184. PubMed ID: 35240430
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.
Lian F; Wang Y; Yang X; Xu H; Liang L
Rheumatol Int; 2012 Jan; 32(1):189-92. PubMed ID: 20798946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]